307180 — Il Science Co Balance Sheet
0.000.00%
- KR₩80bn
- KR₩164bn
- KR₩83bn
Annual balance sheet for Il Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5,798 | 8,052 | 3,080 | 10,041 | 8,306 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,661 | 22,384 | 22,177 | 13,270 | 26,086 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15,468 | 42,867 | 31,435 | 29,798 | 51,529 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18,802 | 24,522 | 33,121 | 35,183 | 61,333 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 40,167 | 72,860 | 72,782 | 79,398 | 138,230 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22,090 | 50,789 | 40,248 | 60,543 | 103,464 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 31,281 | 64,871 | 57,097 | 73,694 | 126,269 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 8,886 | 7,989 | 15,686 | 5,704 | 11,961 |
Total Liabilities & Shareholders' Equity | 40,167 | 72,860 | 72,782 | 79,398 | 138,230 |
Total Common Shares Outstanding |